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Figure 1. Oxybenzone on NaCl windows, FTIR spectra before (1) and
after (2) exposure to light (15 h, Suntest CPS1, Xenon test, 500 Watt
per m2).
spectrum of the layer on the sodium chloride windows were recorded,
before and after exposure to light, on a P.E. System 2000 instument
(Perkin Elmer, Beaconsfield, U.K.).
In both cases no change in the intensities of the carbonyl stretching
bands or other changes in the IR spectrum were observed; Fig 1
shows the transmission FTIR spectra (i) before and (ii) after exposure
to light.
Both experiments show that oxybenzone is very stable under light
and no significant semiquinone is generated.
Finally, if Fig 1 of Schallreuter et al. (1996) is considered it seems
that oxybenzone itself is absent in the Sultan facial cream as many of
the oxybenzone absorbances are not present in the FT Raman spectrum
of the cream. This observation, together with the results of our
investigation, lead us to suspect that the study described in the paper
has not been performed on oxybenzone, but on some other product.
Ettore Santoro
3V Sigma, Bergamo, Italy
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Reply:
We wish to respond to Dr. Santoro’s comment on our paper
‘‘Oxybenzone oxidation following solar irradiation of skin:
photoprotection versus antioxidant inactivation’’ (Schallreuter et al,
1996). There are two major points to address: (i) the stability of
oxybenzone to photo-oxidation in sun protection formulations, and
(ii) whether the Soltan facial cream as used in the above study indeed
contained oxybenzone.
High performance liquid chromatography (HPLC) of Soltan facial
cream SPF 25 purchased in June 1995, proves the presence of
oxybenzone as claimed on the label of this product (Fig 1A). The
absence of some Raman absorbances in Soltan facial cream has been
elucidated in more detail and is most likely due to pi–pi interactions
with other aromatic compounds such as Parsol 1789 and Parsol MCX.
HPLC analysis of the recovery of oxybenzone after ultraviolet (UV)
exposure (5 d exposure time) shows 80% photodegradation of this
ultraviolet A (UVA) filter (Fig 1B). Recently, Heinsohn et al1 claimed
1Heinsohn G, Rapp C, Gers-Barlag H: FT-Raman Spectroscopy – a suitable
method for photostablility testing of sunscreens. International Conference on
Photobiology, Vienna (September 1996).
Figure 1. (A) HPLC profile with retention time for oxybenzone from
Soltan Facial SPF 25 cream. A 250 nm Spherisorb ODS2 column with a
bead size of 5 µm was used together with a gradient of 80% methanol: 20%
0.05 M ortho phosphoric acid solution to 100% methanol over 15 min and a
flow rate of 1 ml per min. Rainin FPLC/HPLC Dynamax SD 300 Solvent
Delivery Systems and Dynamax UV-1 detector (Anachem, Luton, U.K.) were
employed with UV detection at 334 nm. (B) The effect of UV exposure on
SPF 25 sunscreen product examined by HPLC. The UV filter oxybenzone
was studied before and after exposure to normal sunlight. Composition of
oxybenzone in the cream was established and compared daily using a freshly
prepared standard. The results are based on the mean of three analyses.
Figure 2. FT Raman spectra of Soltan sun lotion containing 3.83%
oxybenzone (a) before ultraviolet B (UVB) irradiation, (b) after
0.3 J UVB irradiation per cm2, and (c) after 0.9 J UVB irradiation per
cm2. The peaks are assigned as aromatic ring stretches with the mono-
substituted ring stretch at 1598 per cm and the 1,2,4-tri-substituted aromatic
ring stretch at 1625 per cm. After 0.3 J UVB irradiation per cm2, there is a 9%
decrease in the intensity of the 1,2,4-tri-substituted ring stretch indicating a
loss of aromaticity with no effect on the mono-substituted ring stretch. After
0.9 J irradiation per cm2, there is a considerable decrease in both tri-and mono-
substituted ring stretches showing a loss of aromaticity in the ring structures of
oxybenzone.
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photostability for oxybenzone with a 5% solution after simulated
sunlight exposure over 4 h using FT Raman spectroscopy and HPLC;
however, careful analysis of their data on the recovery of oxybenzone
shows 7.7% photodegradation (i.e., 2 3 10–2 M). The loss of
aromaticity of oxybenzone after UV exposure can be followed by
standardized FT Raman spectroscopy, indicating the formation of a
semiquinone intermediate (Fig 2). In addition, we were able to show
that oxybenzone, upon UVA exposure, oxidizes the essential cofactor
(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin (6BH4), whereas UVA
alone cannot promote this reaction. Under certain conditions, this
oxidation can be cytotoxic to epidermal melanocytes (Schallreuter et al,
1994; Moore et al, 1997).
The FTIR experiment presented in Dr. Santoro’s letter shows one
experiment using the pure stable phenol form of oxybenzone during
the entire study without consideration of the unstable phenolate anion.
The stable phenol form of oxybenzone is in equlibrium with the
unstable phenolate which undergoes photo-oxidation yielding a
semiquinone radical intermediate. This free radical can react with O2
producing O2
– and oxybenzone semiquinone. This proposed reaction
pathway mimics the established formation of the ubiquinone
semiquinone radical produced as intermediate in the electron transport
chain. Therefore Dr. Santoro’s findings on the stability are obtained
Raman Spectroscopic Studies Showing the UV Stability of
Oxybenzone
To the Editor:
In an article on the photostability of the sunscreen oxybenzone
recently published in this Journal it was concluded on the basis of
Raman spectroscopic measurements alone that this sunscreen is not
photostable (Schallreuter et al, 1996). This finding is not only
extraordinary, it also contradicts our own findings as well as
published stability data (Roscher et al, 1994). As our department
uses Raman spectroscopy for a wide variety of sunscreen analyses,1,2
we were interested in clarifying this contradiction and conducted
our own experiments.
Using Raman spectroscopy, we first analyzed a commercial sample
of Soltan facial cream SPF25. The resulting Raman spectrum
Figure 1. Raman spectra of (a) Soltan facial cream, (b) pure oxybenzone,
and (c) Soltan facial cream spiked with 3% oxybenzone.
under special conditions and cannot be compared with commercial
oxybenzone formulations that will always contain an equilibrium of
the phenol and phenolate forms.
In summary we conclude that oxybenzone in formulations is a
photo-active molecule that under oxidative conditions can produce
potentially damaging electrophiles in the skin (Sundaram et al, 1990;
Schallreuter et al, 1996; Moore et al, 1997).
Karin U. Schallreuter, Jeremy Moore, John M. Wood
Clinical and Experimental Dermatology, Department of Biomedical
Sciences, University of Bradford, Bradford, U.K.
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(Fig 1a) agreed very well with the spectrum of Schallreuter et al.
Surprisingly, neither spectrum showed the Raman band at 1000 per
cm that is expected for monosubstituted aromatic compounds and
is found in the spectrum of pure oxybenzone (Fig 1b); however,
we did observe this typical Raman signal after spiking the Soltan
cream sample with 3% oxybenzone (Fig 1c). Closer inspection of
the spectra in Fig 1(b,c) revealed several additional bands typical of
oxybenzone.
Because the Raman measurement provided no clear proof of the
presence of oxybenzone in the commercial Soltan facial cream
sample, we then performed a qualitative and quantitative analysis of
the sample using high performance liquid chromatography. As
expected, these results likewise provided no indication of the
presence of oxybenzone. They did, however, show the presence of
octyl methoxycinnamate (6%) and butyl methoxydibenzoylmethane
(2.8%).
It therefore seemed very likely that the sun cream used by
Schallreuter et al did not contain any oxybenzone, as these authors
assumed. This led us to study the stability of pure oxybenzone and
oxybenzone in an oil in water stearate emulsion after UV irradiation
(4 h, simulated midday sun). Although a small percentage of
oxybenzone was degraded, it is impossible to conclude a general
photoinstability of the substance.
It is also impossible to make any statements on the stability of
oxybenzone on the basis of the studies by Schallreuter et al because
this sunscreen most likely was not present in the cream sample
they investigated. Hence all other conclusions on the further reaction
of the proposed semiquinone are highly questionable.
Claudius Rapp, Guido Heinsohn, Ulrich Hintze
Central Analytical Department, Beiersdorf AG, Hamburg,
Germany
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